Perbedaan Cipta Sarana Medika Tbk. dan Merck Tbk.: Cipta Sarana Medika Tbk. diperdagangkan di Rp63 (kapitalisasi pasar 158,12 M, volume 24 jam 8,21 jt), sedangkan Merck Tbk. diperdagangkan di Rp3.800 (kapitalisasi pasar 1,68 T, volume 24 jam 33,3 rb). Perbedaan utamanya: Merck Tbk. jauh lebih besar — sekitar 10,6× kapitalisasi pasar Cipta Sarana Medika Tbk., dan Cipta Sarana Medika Tbk. lebih aktif diperdagangkan (8,21 jt vs 33,3 rb). Mana yang lebih baik tergantung tujuan investasimu.
| DKHH | MERK | |
|---|---|---|
Kapitalisasi Pasar | 158,12 M | 1,68 T |
Volume | 8,21 jt | 33,3 rb |
Lot | 82,15 rb | 333 |
Perputaran | 515,2 jt | 126,46 jt |
Harga Rata-rata | 62,72 | 3.797,72 |
Nilai Transaksi | 515,2 jt | 126,46 jt |
Harga Ekuilibrium Indikatif | 63 | 3.800 |
Volume Ekuilibrium Indikatif | 1,33 rb | 9 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Selengkapnya di halaman DKHH →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Selengkapnya di halaman MERK →